ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

  • 1.

    Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239–259 (1991).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 2.

    Wischik, C. M. et al. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl Acad. Sci. USA 85, 4506–4510 (1988).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 3.

    Grundke-Iqbal, I. et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 4913–4917 (1986).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 4.

    Whitwell, J. L. et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer’s disease: a…

  • Read more…